GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following is a reconciliation of goodwill by business segment.

(in millions)	Americas		EMEA		APAC		Medical Products and Therapies		Healthcare Systems and Technologies1		Pharmaceuticals		Kidney Care		Total
December 31, 2021	$	2,099	$	309	$	224	$	—	$	6,786	$	—	$	—	$	9,418
Impairments	—		—		—		—		(2,812)		—		—		(2,812)
Measurement period adjustments	—		—		—		—		49		—		—		49
Currency translation	(134)		(20)		(14)		—		(35)		—		—		(203)
December 31, 2022	$	1,965	$	289	$	210	$	—	$	3,988	$	—	$	—	$	6,452
Currency translation and other	(27)		(4)		(3)		46		1		21		28		62
Reallocation of goodwill	(1,938)		(285)		(207)		1,195		—		542		693		—
December 31, 2023	$	—	$	—	$	—	$	1,241	$	3,989	$	563	$	721	$	6,514

1Prior to the third quarter of 2023, our Healthcare Systems and Technologies segment was referred to as our Hillrom segment.

Other Intangible Assets, Net

The following is a summary of our other intangible assets.

									Indefinite-lived intangible assets
(in millions)	Customer relationships		Developed technology, including patents		Trade Names		Other amortized intangible assets		Trade Names		In process Research and Development		Total
December 31, 2023
Gross other intangible assets	$	3,446	$	3,823	$	1,106	$	120	$	680	$	157	$	9,332
Accumulated amortization	(689)		(2,285)		(180)		(99)		—		—		(3,253)
Other intangible assets, net	$	2,757	$	1,538	$	926	$	21	$	680	$	157	$	6,079
December 31, 2022
Gross other intangible assets	$	3,442	$	3,836	$	209	$	116	$	1,571	$	202	$	9,376
Accumulated amortization	(460)		(1,888)		(147)		(88)		—		—		$	(2,583)
Other intangible assets, net	$	2,982	$	1,948	$	62	$	28	$	1,571	$	202	$	6,793